These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2233517)

  • 1. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.
    Mandell L; Ghavimi F; LaQuaglia M; Exelby P
    Med Pediatr Oncol; 1990; 18(6):466-71. PubMed ID: 2233517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
    Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
    J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered.
    Welmant J; Helfre S; Carton M; Bolle S; Minard-Colin V; Corradini N; Pannier S; Rome A; Mansuy L; Vérité C; Castex MP; Kerr C; Defachelles AS; Bernier V; Orbach D
    Strahlenther Onkol; 2021 Aug; 197(8):690-699. PubMed ID: 33914102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
    Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
    Pedrick TJ; Donaldson SS; Cox RS
    J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
    Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
    J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in childhood rhabdomyosarcoma of the extremity.
    Ghavimi F; Mandell LR; Heller G; Hajdu SI; Exelby P
    Cancer; 1989 Dec; 64(11):2233-7. PubMed ID: 2804912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study.
    Terwisscha van Scheltinga CEJ; Wijnen MHWA; Martelli H; Guerin F; Rogers T; Craigie RJ; Burrieza GG; Dall'Igna P; De Corti F; Smeulders N; van Rijn RR; Fajardo RD; Mandeville HC; Zanetti I; Coppadoro B; Minard-Colin V; Jenney M; Bisogno G; van Noesel MM; van der Steeg AFW; Merks JHM
    Eur J Surg Oncol; 2022 Jul; 48(7):1536-1542. PubMed ID: 35307252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
    Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
    J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
    La TH; Wolden SL; Rodeberg DA; Hawkins DS; Brown KL; Anderson JR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1151-7. PubMed ID: 20542386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of mortality in pediatric extremity rhabdomyosarcoma.
    LaQuaglia MP; Ghavimi F; Penenberg D; Mandell LR; Healey JH; Hadju SI; Exelby PR
    J Pediatr Surg; 1990 Feb; 25(2):238-43; discussion 243-4. PubMed ID: 2303993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
    JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy.
    Mandell L; Ghavimi F; Peretz T; LaQuaglia M; Exelby P
    J Clin Oncol; 1990 Sep; 8(9):1536-42. PubMed ID: 2391558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
    Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.